跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Orovite-E
Approved
STANDARD
Orovite-E
Hizon Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
094ed499a6c9c6f1
Company
Hizon Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
094ed499a6c9c6f1
Drug Approval Philippines Name
Orovite-E
Product Name
Orovite-E
Registration Number
DR-XY45425
Brand Name
Orovite-E
Generic Name
D-Alpha -Tocopherol (Vitamin E)
Dosage Form
Softgel Capsule
Dosage Strength
400 IU
Manufacturer
Hizon Laboratories, Inc.
Trader
PNSV Asia Corporation
Issuance Date
24 March 2021
Expiry Date
06 June 2026
Pharmacologic Category
Vitamin
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
094ed499a6c9c6f1
Type
Standard
Back to Philippines FDA Approvals
Orovite-E - Philippines FDA Drug Approval Details